Cite
APA Citation
Mehanna, H., Kong, A., Hartley, A., Mistry, P., Dalby, M., Fulton-Lieuw, T., Robinson, M., Gray, A., Foran, B., Sen, M., O'Toole, L., Dyker, K., Al Booz, H., Moleron, R., Brennan, S., Aynsley, E., Chan, A., Srinivasan, D., Buter, J., & Dunn, J. (n.d.). lBA9_PRCetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095494175.0x000035